Conmed Profit Margin

The latest profit margin for CNMD is 5.36% as of September 2026. That compares with 4.75% in the prior-year period — up 13.0% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Conmed's historical trend and sector peers before judging valuation or financial health.

Over the past year, CNMD's profit margin moved from 4.75% to 5.36% — a 13.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Conmed's valuation or profitability profile.

Against Healthcare companies, CNMD currently prints 5.36% for profit margin, while the sector average sits near 9.48%. That is roughly 43.4% below the sector mean. Large gaps often invite a closer look at Conmed's growth, margins, and balance sheet.

Profit Margin shows how effectively Conmed converts resources into returns. At 5.36%, CNMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.75% in the prior-year period — up 13.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CNMD's profit margin (5.36%), review year-over-year change from 4.75%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.